2006
Pathology of B-cell non-Hodgkin's lymphomas and multiple myeloma. Cancer Treat Res. 2006;131:1-48.
"Fauna-form" changes in breast. Am J Surg Pathol. 2006;30(3):416.
Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and BCL2A1 as critical target genes. J Clin Invest. 2006;116(12):3171-82.
Diagnostic endoscopy in children after hematopoietic stem cell transplantation. Gastrointest Endosc. 2006;64(3):379-85; quiz 389-92.
Differential activation of IFN regulatory factor (IRF)-3 and IRF-5 transcription factors during viral infection. J Immunol. 2006;176(12):7462-70.
Unusual variants of malignant melanoma. Mod Pathol. 2006;19 Suppl 2:S41-70.
GR 63799X, an EP3 receptor agonist, induced S phase arrest and 3T6 fibroblast growth inhibition. Eur J Pharmacol. 2006;529(1-3):16-23.
Unusual histologic and clinical variants of melanoma: implications for therapy. Curr Treat Options Oncol. 2006;7(3):169-80.
C3d and the septal microvasculature as a predictor of chronic lung allograft dysfunction. Hum Immunol. 2006;67(4-5):274-83.
